🔥 Friday 7 February 2025 Fri, 7 Feb 2025

39 Big Stories

Atlas Arteria Braces for Hefty New French Supplemental Tax in 2025

Atlas Arteria reveals it will face a significant temporary supplemental tax under France’s new 2025 Finance Law, impacting its APRR Group operations with payments due late next year.
7 Feb
Nora Hopper
Nora Hopper

Charter Hall Long WALE REIT Delivers Steady Growth and Confirms FY25 Outlook

Charter Hall Long WALE REIT reported a resilient half-year performance with near-full occupancy and solid income growth, reaffirming its FY25 earnings and distribution guidance amid strategic portfolio adjustments.
7 Feb
Eva Park
Eva Park

Charter Hall Long WALE REIT Bounces Back with $51.3M Profit in H1 2024

Charter Hall Long WALE REIT has reversed last year’s heavy losses, reporting a statutory profit of $51.3 million for the half year ended December 2024, while maintaining steady distributions to investors.
7 Feb
Eva Park
Eva Park

HPI Boosts Distribution Guidance Amid Governance Shake-Up and Portfolio Enhancements

Hotel Property Investments (HPI) reported a resilient H1 FY25 with a $1.26 billion portfolio and upgraded its distribution guidance to 19.7 cents per security, despite significant governance changes amid a takeover bid.
7 Feb
Eva Park
Eva Park

HPI Posts $16.7M Profit, Boosts FY25 Distribution Guidance Amid Debt Refinancing

Hotel Property Investments (HPI) reported a solid $16.7 million statutory profit for H1 FY25, alongside a 3.2% rise in distributions and a successful debt refinancing that extends maturity and reduces costs.
7 Feb
Eva Park
Eva Park

AdAlta Advances 'East to West' Strategy to Revolutionize Solid Cancer Therapies

AdAlta Limited is accelerating its 'East to West' cellular immunotherapy strategy, aiming to bridge Asian innovation with Western clinical development and manufacturing to target solid cancers. The company plans to secure three assets by the end of 2025 and initiate clinical trials, positioning itself as a leader in this emerging market.
7 Feb
Ada Torres
Ada Torres

HPI Posts A$16.7M Profit, Navigates Takeover Bids with Steady Distributions

Hotel Property Investments (HPI) reported a robust half-year profit of A$16.7 million, driven by rising rental income and property valuations, while managing significant takeover defence costs amid Charter Hall Retail REIT and Hostplus bids.
7 Feb
Eva Park
Eva Park

Aruma Resources Targets New Gold Zones with 2,000m Drilling at Salmon Gums

Aruma Resources is set to launch a 2,000-metre aircore drilling campaign at its Salmon Gums Gold Project, aiming to unlock new high-potential gold prospects identified through recent geological reinterpretations.
7 Feb
Maxwell Dee
Maxwell Dee

Tempest Minerals Joins $3B Green Steel Push with WA Magnetite Deal

Tempest Minerals has signed a Memorandum of Understanding with Green Steel and Iron to develop a $3 billion hot briquette iron processing hub near its Yalgoo Project, aiming to supply high-grade magnetite for green steelmaking.
7 Feb
Maxwell Dee
Maxwell Dee

Enova Mining Unveils Major High-Grade Titanium Discovery at CODA North

Enova Mining has reported multiple high-grade titanium dioxide intercepts exceeding 15% TiO2 at its CODA North project, highlighting significant multi-commodity potential alongside rare earth elements.
7 Feb
Maxwell Dee
Maxwell Dee

Lord Resources Identifies New Gravity Anomalies at Ilgarari Copper Project

Lord Resources has uncovered significant gravity anomalies at its Ilgarari Copper Project, revealing promising new drill targets and commencing an earn-in agreement to secure an 80% interest in the sulphide rights.
7 Feb
Maxwell Dee
Maxwell Dee

Nick Scali Surpasses Profit Guidance as UK Expansion Faces Growing Pains

Nick Scali Limited reported a stronger-than-expected half-year profit, driven by solid ANZ performance, while its UK operations continue to face restructuring challenges amid store refurbishments.
7 Feb
Logan Eniac
Logan Eniac

Nick Scali Reports 30% Profit Drop Amid UK Expansion Challenges

Nick Scali Limited’s half-year results reveal a 30.2% decline in statutory profit, impacted by UK acquisition losses and restructuring costs, yet the company maintains shareholder returns with a fully franked interim dividend.
7 Feb
Logan Eniac
Logan Eniac

News Corp Posts 80% Net Income Surge, Foxtel Sale Reshapes Strategy

News Corporation reported a robust half-year performance with revenues up 4% to $4.33 billion and net income soaring 80% to $334 million, while advancing its strategic pivot through the planned sale of Foxtel.
7 Feb
Elise Vega
Elise Vega

Neuren Secures FDA Type C Meeting to Finalise Phase 3 Trial Design for Rare Syndrome

Neuren Pharmaceuticals has secured a pivotal FDA Type C Meeting to discuss primary efficacy endpoints for its Phase 3 trial of NNZ-2591 targeting Phelan-McDermid syndrome, advancing its rare disease drug development.
7 Feb
Victor Sage
Victor Sage